Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT India 100BT GolfBT Mindrush
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
mutual funds
nippon india pharma fund - direct plan - growth plan
Nippon India Pharma Fund - Direct Plan - Growth Plan

Nippon India Pharma Fund - Direct Plan - Growth Plan

  • Very High Risk
  • Equity
  • Sector - Healthcare
Share
  • Whatsapp
  • Twitter
  • Facebook
NAV as on Jul 30, 2025
i
Price per unit of the scheme.
₹ 598.08540.24%1 Day Change
3.53%
Minimum Investment₹5000
Expense Ratio1.03%

FUND RATING

A holistic measure of the rank of a fund relative to its peers. Top funds receive a score of 5.
*Morningstar Rating Methodologyi
i

RISK-O-METER

Level of risk associated with a mutual fund to help investors make informed investment decisions
 

bt_logoFUND PERFORMANCE

As On Jan 01, 2023
Compare fund’s performance against category average across different time periods


No Data Found.
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
For calculating Category Return & Scheme Ranking, only Growth & Direct schemes are considered.

bt_logoFUND COMPARISON

1M3M6M1Y3Y5Y
This Fund
Nippon India Pharma Fund - Direct Plan - Growth Plan
VS
Equity: Sector - Healthcare Average NAV
    Topper in Equity: Sector - Healthcare
    All Fund


    No Data Found.
    *For the other fund, rescaled NAVs are used
    Share
    • Whatsapp
    • Twitter
    • Facebook

    bt_logoRETURN CALCULATOR

    Check the return on your investment in the fund
    Nippon India Pharma Fund - Direct Plan - Growth Plan
    Investment Type
    Monthly Investment
    Time Period (yrs)
    Annual Return in %
    • Invested Amount
      ₹0
    • Return
      ₹0
    • Current Value
      ₹0

    bt_logoFUND SUMMARY

    Benchmark
    S&P BSE Healthcare TR INR
    Expense Ratio
    1.03%
    Category Avg Expense Ratio
    1.01%
    Minimum Investment (Lumpsum/SIP)
    ₹ 5000 /₹ 100
    Lock In (Years)
    No Lock-in
    Fund Size
    ₹ 8,569.15 Cr(As on Jun, 2025)
    Inception Date
    Jan 01, 2013
    Turnover
    21.00 %
    Exit Load
    1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units. Nil, thereafter.

    bt_logoABOUT THE FUND

    Objective: The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

    Nippon India Pharma Fund - Direct Plan - Growth Plan is an Equity - Sector - Healthcare fund. The fund was launched inJan 01, 2013. Its risk level is . The NAV of the fund as onJul 30, 2025 is ₹598.09. Its expense ratio is 1.03 %. The fund has an AUM of ₹8,569.15 Cr.The fund is managed bySailesh Raj Bhan,Akshay Sharma,Kinjal Desai.
    The minimum initial investment is  ₹5000 in Lumpsum mode.

    SUBSCRIBE TO
    BUSINESS TODAY MAGAZINE
    Subscribe Now
    Already a subscriber?Login

    bt_logoFUND MANAGER

    Sailesh Raj Bhan
    Sailesh Raj Bhan
    i
    Lead Fund Manager.
    Apr 1, 2005 - Present
    • Fund Manager Rank10Out of 10
      i
      Rank measured on the basis of consistent alpha the fund manager delivered in the same category over a period of three years (factors only Direct plan, Growth option)
    • Schemes managed3
    • Total AUM₹ 97,763.84 Cr
    • Highest Return In 1 Yr11.91 %
    Other Funds
    • table
    • card
    1M
    3M
    6M
    1Y
    3Y
    5Y
    Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size
    Nippon India Pharma Fund - Direct Plan - Growth Plan
    --
    ₹ 598.09
    3.53%
    3.99%
    Very High Risk
    ₹8,569.15Cr
    Nippon India Multi Cap Fund - Direct Plan - Growth
    ₹ 329.84
    -0.66%
    -1.71%
    Very High Risk
    ₹45,366.09Cr
    Nippon India Large Cap Fund - Direct Plan - Growth Plan
    ₹ 100.69
    -1.62%
    -2.22%
    Very High Risk
    ₹43,828.60Cr
    Nippon India Pharma Fund - Direct Plan - Growth Plan
    Very High Risk--
    • NAV₹ 598.09
    • Fund Size₹8,569.15Cr
    Fund Return3.53%
    Category Return3.99%
    Nippon India Multi Cap Fund - Direct Plan - Growth
    Very High Risk
    • NAV₹ 329.84
    • Fund Size₹45,366.09Cr
    Fund Return-0.66%
    Category Return-1.71%
    Nippon India Large Cap Fund - Direct Plan - Growth Plan
    Very High Risk
    • NAV₹ 100.69
    • Fund Size₹43,828.60Cr
    Fund Return-1.62%
    Category Return-2.22%
    Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
    Akshay Sharma
    Akshay Sharma
    i
    Lead Fund Manager.
    Dec 1, 2022 - Present
    • Schemes managed51
    • Total AUM₹ 4,36,510.51 Cr
    • Highest Return In 1 Yr340.03 %
    Other Funds
    • table
    • card
    1M
    3M
    6M
    1Y
    3Y
    5Y
    Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size
    Nippon India Pharma Fund - Direct Plan - Growth Plan
    --
    ₹ 598.09
    3.53%
    3.99%
    Very High Risk
    ₹8,569.15Cr
    Nippon India Small Cap Fund - Direct Plan - Growth Plan
    ₹ 191.06
    -1.60%
    -0.95%
    Very High Risk
    ₹66,601.80Cr
    Nippon India Balanced Advantage Fund Direct Growth Plan
    ₹ 199.57
    -0.54%
    -0.80%
    High Risk
    ₹9,390.89Cr
    Nippon India Pharma Fund - Direct Plan - Growth Plan
    Very High Risk--
    • NAV₹ 598.09
    • Fund Size₹8,569.15Cr
    Fund Return3.53%
    Category Return3.99%
    Nippon India Small Cap Fund - Direct Plan - Growth Plan
    Very High Risk
    • NAV₹ 191.06
    • Fund Size₹66,601.80Cr
    Fund Return-1.60%
    Category Return-0.95%
    Nippon India Balanced Advantage Fund Direct Growth Plan
    High Risk
    • NAV₹ 199.57
    • Fund Size₹9,390.89Cr
    Fund Return-0.54%
    Category Return-0.80%
    Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
    Kinjal Desai
    Kinjal Desai
    i
    Lead Fund Manager.
    May 25, 2018 - Present
    • Schemes managed52
    • Total AUM₹ 4,36,516.68 Cr
    • Highest Return In 1 Yr340.03 %
    Other Funds
    • table
    • card
    1M
    3M
    6M
    1Y
    3Y
    5Y
    Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size
    Nippon India Small Cap Fund - Direct Plan - Growth Plan
    ₹ 191.06
    -1.60%
    -0.95%
    Very High Risk
    ₹66,601.80Cr
    Nippon India Credit Risk Fund Direct Plan Growth Option
    ₹ 38.95
    1.02%
    0.60%
    High Risk
    ₹1,018.01Cr
    Nippon India Pharma Fund - Direct Plan - Growth Plan
    --
    ₹ 598.09
    3.53%
    3.99%
    Very High Risk
    ₹8,569.15Cr
    Nippon India Small Cap Fund - Direct Plan - Growth Plan
    Very High Risk
    • NAV₹ 191.06
    • Fund Size₹66,601.80Cr
    Fund Return-1.60%
    Category Return-0.95%
    Nippon India Credit Risk Fund Direct Plan Growth Option
    High Risk
    • NAV₹ 38.95
    • Fund Size₹1,018.01Cr
    Fund Return1.02%
    Category Return0.60%
    Nippon India Pharma Fund - Direct Plan - Growth Plan
    Very High Risk--
    • NAV₹ 598.09
    • Fund Size₹8,569.15Cr
    Fund Return3.53%
    Category Return3.99%
    Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

    bt_logoDETAILED PORTFOLIO

    As on Jun, 2025
    EQUITY (99.47%)
    DEBT (-%)
    CASH (0.53%)
    Allocation by Market Cap
    Large Cap(35.06%)
    Mid Cap(31.99%)
    Small Cap(32.41%)
    Industry Holdings
    • Drug Manufacturers Specialty Generic62.98%
    • Diagnostics Research12.24%
    • Medical Care10.11%
    • Drug Manufacturers Major8.92%
    • Pharmaceutical Retailers New3.85%
    • Biotechnology1.89%
    Stock Holdings
    • Sun Pharmaceuticals Industries Ltd12.23%
    • Divi's Laboratories Ltd8.50%
    • Lupin Ltd6.07%
    • Cipla Ltd5.62%
    • Apollo Hospitals Enterprise Ltd5.48%
    • Dr Reddy's Laboratories Ltd5.18%

    bt_logoPERFORMANCE MEASURES

    Fund evaluation across critical parameters for better decision making. Study period is 3 years.
    • Consistency
      i
      It represents the consistency of a fund in beating its benchmark.
    • Downside Risk
      i
      Measured by Maximum Drawdown which shows the maximum loss from a peak to a nadir over a specified time period
    • Risk Adjusted Return
      i
      Risk adjusted return represents the return generated after factoring the risk taken to achieve it.
    • Volatility
      i
      Volatility represents the standard deviation of fund returns that is, how much the fund returns have deviated from the average.
    • Upside Capture Ratio
      i
      Fund performance relative to the index when the market is up. An upside capture ratio of >100 indicates better fund performance.
    • Downside Capture Ratio
      i
      Fund performance relative to the index when the market is down. A downside capture ratio of <100 indicates better fund performance.

    bt_logoHISTORICAL RISK MEASURES

    Statistical measures to evaluate mutual fund risk. All ratios are calculated for a three-year time duration.
    • Alpha: Excess return of the fund over benchmark
      i
      Any Alpha above zero is considered good. However, for comparison, a fund with a higher Alpha is considered better. Alpha is normally used in conjunction with Beta. If the Beta is high, it implies that the fund manager took a high risk to generate Alpha.
      1.62
      This Fund
      VS
      -0.28
      Category Avg
    • R-Squared: How well the fund tracks benchmark
      i
      R-Squared measures the correlation of fund returns and its benchmark returns. It varies between 0 and 1. The metric, Beta makes no sense if R-Squared is equal to zero. Thus, both Beta and R-Squared should be used in conjunction. A fund with a high R-Squared and low Beta is considered a less risky fund.
      94.50
      This Fund
      VS
      94.10
      Category Avg
    • Beta: Risk of the fund in relation to benchmark
      i
      Beta >1 indicates that the fund is more volatile than its benchmark while Beta < 1 indicates that the fund is less volatile than its benchmark. The Beta of the benchmark is equal to 1.
      0.90
      This Fund
      VS
      0.96
      Category Avg
    • Sharpe Ratio: Risk adjusted return of the fund
      i
      Sharpe Ratio is a measure of return per unit of risk. A higher Sharpe ratio indicates better risk adjusted return given by the fund.
      1.26
      This Fund
      VS
      1.14
      Category Avg
    • Sortino Ratio: Return per unit of bad risk
      i
      A variation of Sharpe ratio, Sortino considers only the downside risk. Unlike Sharpe ratio which considers both good risk and bad risk, Sortino factors only the bad risk. A high Sortino ratio indicates better return for each unit of downside risk.
      2.36
      This Fund
      VS
      2.10
      Category Avg
    • Standard Devation: Volatility of the fund
      i
      Standard deviation is a measure of dispersion of fund returns from its average return. A fund with a higher Standard deviation is more volatile than a fund with a low standard deviation.
      14.76
      This Fund
      VS
      15.76
      Category Avg
    Benchmark used in calculation : S&P BSE 500 India TR INR

    bt_logoPEER ANALYSIS

    1M
    3M
    6M
    1Y
    3Y
    5Y
    • card
    • table
    Fund NameMorningstar RatingNAV Fund Return Category ReturnRisk Fund Size
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
    --
    ₹ 44.69
    5.35%
    3.99%
    Very High Risk
    ₹ 5,727.59 Cr
    Mirae Asset Healthcare Fund Direct GrowthMirae Asset Healthcare Fund Direct Growth
    --
    ₹ 44.73
    5.25%
    3.99%
    Very High Risk
    ₹ 2,785.12 Cr
    DSP Healthcare Fund Direct GrowthDSP Healthcare Fund Direct Growth
    --
    ₹ 45.15
    4.94%
    3.99%
    Very High Risk
    ₹ 3,056.90 Cr
    UTI Healthcare Fund-Growth Option- DirectUTI Healthcare Fund-Growth Option- Direct
    --
    ₹ 338.07
    4.84%
    3.99%
    Very High Risk
    ₹ 1,098.70 Cr
    IDBI Healthcare Fund Direct GrowthIDBI Healthcare Fund Direct Growth
    --
    ₹ 33.17
    4.68%
    3.99%
    Very High Risk
    ₹ 87.70 Cr
    Aditya Birla Sun Life Pharma & Healthcare Fund Direct GrowthAditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
    --
    ₹ 35.33
    4.59%
    3.99%
    Very High Risk
    ₹ 840.48 Cr
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
    Very High Risk--
    • NAV₹ 44.69
    • Fund Size₹ 5,727.59 Cr
    Fund Return5.35%
    Category Return3.99%
    Mirae Asset Healthcare Fund Direct Growth
    Very High Risk--
    • NAV₹ 44.73
    • Fund Size₹ 2,785.12 Cr
    Fund Return5.25%
    Category Return3.99%
    DSP Healthcare Fund Direct Growth
    Very High Risk--
    • NAV₹ 45.15
    • Fund Size₹ 3,056.90 Cr
    Fund Return4.94%
    Category Return3.99%
    UTI Healthcare Fund-Growth Option- Direct
    Very High Risk--
    • NAV₹ 338.07
    • Fund Size₹ 1,098.70 Cr
    Fund Return4.84%
    Category Return3.99%
    IDBI Healthcare Fund Direct Growth
    Very High Risk--
    • NAV₹ 33.17
    • Fund Size₹ 87.70 Cr
    Fund Return4.68%
    Category Return3.99%
    Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
    Very High Risk--
    • NAV₹ 35.33
    • Fund Size₹ 840.48 Cr
    Fund Return4.59%
    Category Return3.99%
    Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

    bt_logoTOP FUNDS FROM THIS AMC

    1M
    3M
    6M
    1Y
    3Y
    5Y
    • card
    • table
    Fund NameMorningstar RatingNAV Fund Return Category Return Risk Fund Size (Cr)
    Nippon India Credit Risk Fund Segregated Portfolio 1 Direct GrowthNippon India Credit Risk Fund Segregated Portfolio 1 Direct Growth
    --
    ₹ 0.53
    298.36%
    --
    High Risk
    ₹ 23.68 Cr
    Nippon India Strategic Debt Fund Segregated Portfolio 1 Direct GrowthNippon India Strategic Debt Fund Segregated Portfolio 1 Direct Growth
    --
    ₹ 0.19
    297.89%
    --
    Very High Risk
    ₹ 6.16 Cr
    Nippon India Equity Savings Segregated Portfolio 1 Direct Plan Growth Plan Growth OptionNippon India Equity Savings Segregated Portfolio 1 Direct Plan Growth Plan Growth Option
    --
    ₹ 0.68
    126.02%
    --
    Moderate Risk
    ₹ 25.81 Cr
    Nippon India Equity Savings Segregated Portfolio 1 Direct Plan Growth Plan Bonus OptionNippon India Equity Savings Segregated Portfolio 1 Direct Plan Growth Plan Bonus Option
    --
    ₹ 0.68
    126.02%
    --
    Moderate Risk
    ₹ 25.81 Cr
    Nippon India Equity Hybrid Fund Segregated Portfolio 1 Direct Plan Growth PlanNippon India Equity Hybrid Fund Segregated Portfolio 1 Direct Plan Growth Plan
    --
    ₹ 0.13
    125.99%
    --
    Very High Risk
    ₹ 9.33 Cr
    Nippon India Silver ETF Fund of Fund (FOF) Direct GrowthNippon India Silver ETF Fund of Fund (FOF) Direct Growth
    --
    ₹ 17.70
    7.19%
    4.66%
    Very High Risk
    ₹ 863.64 Cr
    Nippon India Credit Risk Fund Segregated Portfolio 1 Direct Growth
    High Risk--
    • NAV₹ 0.53
    • Fund Size₹ 23.68 Cr
    1 Month Return298.36%
    Category Return--
    Nippon India Strategic Debt Fund Segregated Portfolio 1 Direct Growth
    Very High Risk--
    • NAV₹ 0.19
    • Fund Size₹ 6.16 Cr
    1 Month Return297.89%
    Category Return--
    Nippon India Equity Savings Segregated Portfolio 1 Direct Plan Growth Plan Growth Option
    Moderate Risk--
    • NAV₹ 0.68
    • Fund Size₹ 25.81 Cr
    1 Month Return126.02%
    Category Return--
    Nippon India Equity Savings Segregated Portfolio 1 Direct Plan Growth Plan Bonus Option
    Moderate Risk--
    • NAV₹ 0.68
    • Fund Size₹ 25.81 Cr
    1 Month Return126.02%
    Category Return--
    Nippon India Equity Hybrid Fund Segregated Portfolio 1 Direct Plan Growth Plan
    Very High Risk--
    • NAV₹ 0.13
    • Fund Size₹ 9.33 Cr
    1 Month Return125.99%
    Category Return--
    Nippon India Silver ETF Fund of Fund (FOF) Direct Growth
    Very High Risk--
    • NAV₹ 17.70
    • Fund Size₹ 863.64 Cr
    1 Month Return7.19%
    Category Return4.66%
    Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

    bt_logoABOUT THE AMC

    company icon
    Nippon Life India Asset Management Ltd
    Nippon Life India Asset Management Ltd manages assets worth ₹ 6,52,947.28 crores. It’s current offering of mutual fund schemes includes 33 equity, 78 debt and 13 hybrid schemes.
    phone icon
    Phone
    022-6808 7000/18602660111
    mail icon
    Email
    customercare@nipponindiaim.in
    aum
    AUM
    ₹ 6,52,947.28 Cr (
    As on Jun 30, 2025
    )
    location
    Address
    4th Floor, Tower A, Peninsula Business Park, Mumbai,400 013

    bt_logoFAQ's

    What is the category of Nippon India Pharma Fund - Direct Plan - Growth Plan ?
    The category of Nippon India Pharma Fund - Direct Plan - Growth Plan is Equity - Sector - Healthcare
    What is the current NAV of Nippon India Pharma Fund - Direct Plan - Growth Plan ?
    The current NAV of Nippon India Pharma Fund - Direct Plan - Growth Plan as on Jul 30, 2025 is ₹598.09
    How safe is Nippon India Pharma Fund - Direct Plan - Growth Plan ?
    The risk level of Nippon India Pharma Fund - Direct Plan - Growth Plan is Very High.
    What are short term returns given by Nippon India Pharma Fund - Direct Plan - Growth Plan ?
    The return given by Nippon India Pharma Fund - Direct Plan - Growth Plan in 1 month is 3.53%, 3 months is 8.26%, 6 months is 12.53%, and 1 year is 11.91%
    What are the long term returns given by Nippon India Pharma Fund - Direct Plan - Growth Plan ?
    The return given by Nippon India Pharma Fund - Direct Plan - Growth Plan in 3 years is 26.12% and 5 years is 22.37%.
    What is the expense ratio of Nippon India Pharma Fund - Direct Plan - Growth Plan ?
    The expense ratio of Nippon India Pharma Fund - Direct Plan - Growth Plan is 1.03%
    What is the AUM of Nippon India Pharma Fund - Direct Plan - Growth Plan ?
    The assets under Management (AUM) of Nippon India Pharma Fund - Direct Plan - Growth Plan is Rs 8,569.15 crores.
    What is the minimum investment in Nippon India Pharma Fund - Direct Plan - Growth Plan ?
    The minimum Lumpsum investment in Nippon India Pharma Fund - Direct Plan - Growth Plan is ₹5,000.00 and the minimum SIP investment in Nippon India Pharma Fund - Direct Plan - Growth Plan is ₹100.00
    What is the asset allocation of Nippon India Pharma Fund - Direct Plan - Growth Plan?
    Nippon India Pharma Fund - Direct Plan - Growth Plan has an exposure of 99.47% in Equity and 0.53% in Cash & Money Market Securities

    bt_logoCALCULATORS

    calculatorIncome Tax Calculatorsip calculatorSIP Calculatorfd calculatorFD Calculatordividend yield calculatorDividend Yield Calculatorlump sum calculatorLump-Sum Calculatorcagr calculator CAGR Calculatortop up sip calculatorTop-Up Calculatorlatter factor calculatorLatte Factor Calculator

    bt_logoTop Stories